Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

Myungeun Lee, Zhi Hong Lu, Jie Li, Elena A. Kashentseva, Igor P. Dmitriev, Samir A. Mendonca, David T. Curiel

Mol Cancer Ther (2020) 19 (3): 966–971.

https://doi.org/10.1158/1535-7163.MCT-19-0768

Published: 02 March 2020

View articletitled, Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

Journal Articles

Substitution of Adenovirus Serotype 3 Hexon onto a Serotype 5 Oncolytic Adenovirus Reduces Factor X Binding, Decreases Liver Tropism, and Improves Antitumor Efficacy

Joshua J. Short, Angel A. Rivera, Hongju Wu, Mark R. Walter, Masato Yamamoto, J. Michael Mathis, David T. Curiel

Mol Cancer Ther (2010) 9 (9): 2536–2544.

https://doi.org/10.1158/1535-7163.MCT-10-0332

Published: 08 September 2010

View articletitled, Substitution of Adenovirus Serotype 3 Hexon onto a Serotype 5 Oncolytic Adenovirus Reduces Factor X Binding, Decreases Liver Tropism, and Improves Antitumor Efficacy

Journal Articles

Oncolytic adenoviruses targeted to cancer stem cells

Joshua J. Short, David T. Curiel

Mol Cancer Ther (2009) 8 (8): 2096–2102.

https://doi.org/10.1158/1535-7163.MCT-09-0367

Published: 14 August 2009

View articletitled, Oncolytic adenoviruses targeted to cancer stem cells

Journal Articles

MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism

Margaret A. Park, Teneille Walker, Aditi Pandya Martin, Jeremy Allegood, Nicollaq Vozhilla, Luni Emdad, Devanand Sarkar, Mohammed Rahmani, Martin Graf, Adly Yacoub, Costas Koumenis, Sarah Spiegel, David T. Curiel, Christina Voelkel-Johnson, Steven Grant, Paul B. Fisher, Paul Dent

Mol Cancer Ther (2009) 8 (5): 1280–1291.

https://doi.org/10.1158/1535-7163.MCT-09-0073

Published: 13 May 2009

View articletitled, MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism

Includes: Supplementary data

Journal Articles

Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95

Margaret A. Park, Guo Zhang, Clint Mitchell, Mohamed Rahmani, Hossein Hamed, Michael P. Hagan, Adly Yacoub, David T. Curiel, Paul B. Fisher, Steven Grant, Paul Dent

Mol Cancer Ther (2008) 7 (9): 2633–2648.

https://doi.org/10.1158/1535-7163.MCT-08-0400

Published: 11 September 2008

View articletitled, Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95

Includes: Supplementary data

Journal Articles

Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling

Adly Yacoub, Pankaj Gupta, Margaret A. Park, Mohammed Rhamani, Hossein Hamed, David Hanna, Guo Zhang, Devanand Sarkar, Irina V. Lebedeva, Luni Emdad, Costas Koumenis, David T. Curiel, Steven Grant, Paul B. Fisher, Paul Dent

Mol Cancer Ther (2008) 7 (2): 314–329.

https://doi.org/10.1158/1535-7163.MCT-07-2150

Published: 15 February 2008

View articletitled, Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling

Journal Articles

Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells

Adly Yacoub, Margaret A. Park, Pankaj Gupta, Mohammed Rahmani, Guo Zhang, Hossein Hamed, David Hanna, Devanand Sarkar, Irina V. Lebedeva, Luni Emdad, Moira Sauane, Nicollaq Vozhilla, Sarah Spiegel, Costas Koumenis, Martin Graf, David T. Curiel, Steven Grant, Paul B. Fisher, Paul Dent

Mol Cancer Ther (2008) 7 (2): 297–313.

https://doi.org/10.1158/1535-7163.MCT-07-2166

Published: 15 February 2008

View articletitled, Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells

Journal Articles

Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells

Clint Mitchell, Maragret A. Park, Guo Zhang, Adly Yacoub, David T. Curiel, Paul B. Fisher, John D. Roberts, Steven Grant, Paul Dent

Mol Cancer Ther (2007) 6 (12): 3101–3112.

https://doi.org/10.1158/1535-7163.MCT-07-0561

Published: 18 December 2007

View articletitled, Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells

Journal Articles

Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells

Luni Emdad, Irina V. Lebedeva, Zao-Zhong Su, Devanand Sarkar, Paul Dent, David T. Curiel, Paul B. Fisher

Mol Cancer Ther (2007) 6 (11): 2985–2994.

https://doi.org/10.1158/1535-7163.MCT-07-0399

Published: 19 November 2007

View articletitled, Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells

Journal Articles

Radiation-induced cell signaling: inside-out and outside-in

Kristoffer Valerie, Adly Yacoub, Michael P. Hagan, David T. Curiel, Paul B. Fisher, Steven Grant, Paul Dent

Mol Cancer Ther (2007) 6 (3): 789–801.

https://doi.org/10.1158/1535-7163.MCT-06-0596

Published: 15 March 2007

View articletitled, Radiation-induced cell signaling: inside-out and outside-in

Journal Articles

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus

Matthew A. Tyler, Ilya V. Ulasov, Anton Borovjagin, Adam M. Sonabend, Andrey Khramtsov, Yu Han, Paul Dent, Paul B. Fisher, David T. Curiel, Maciej S. Lesniak

Mol Cancer Ther (2006) 5 (9): 2408–2416.

https://doi.org/10.1158/1535-7163.MCT-06-0187

Published: 19 September 2006

View articletitled, Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus

Journal Articles

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

Svetlana Komarova, Yosuke Kawakami, Mariam A. Stoff-Khalili, David T. Curiel, Larisa Pereboeva

Mol Cancer Ther (2006) 5 (3): 755–766.

https://doi.org/10.1158/1535-7163.MCT-05-0334

Published: 16 March 2006

View articletitled, Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

Journal Articles

Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter

Yosef S. Haviv, Winan J. van Houdt, Baogen Lu, David T. Curiel, Zeng B. Zhu

Mol Cancer Ther (2004) 3 (6): 687–691.

https://doi.org/10.1158/1535-7163.687.3.6

Published: 21 June 2004

View articletitled, Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter

Journal Articles

Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures

N. Sanjib Banerjee, Angel A. Rivera, Minghui Wang, Louise T. Chow, Thomas R. Broker, David T. Curiel, Dirk M. Nettelbeck

Mol Cancer Ther (2004) 3 (4): 437–449.

https://doi.org/10.1158/1535-7163.437.3.4

Published: 12 April 2004

View articletitled, Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures

Includes: Supplementary data

Journal Articles

Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy

Mack N. Barnes, Candace J. Coolidge, Akseli Hemminki, Ronald D. Alvarez, David T. Curiel

Mol Cancer Ther (2002) 1 (6): 435–439.

Published: 01 April 2002

View articletitled, Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy

Journal Articles

A Model System for the Design of Armed Replicating Adenoviruses Using p53 as a Candidate Transgene

Yosef S. Haviv, Koichi Takayama, Joel N. Glasgow, Jerry L. Blackwell, Minghui Wang, Xiaosheng Lei, David T. Curiel

Mol Cancer Ther (2002) 1 (5): 321–328.

Published: 01 March 2002

View articletitled, A Model System for the Design of Armed Replicating Adenoviruses Using p53 as a Candidate Transgene

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

Substitution of Adenovirus Serotype 3 Hexon onto a Serotype 5 Oncolytic Adenovirus Reduces Factor X Binding, Decreases Liver Tropism, and Improves Antitumor Efficacy

Oncolytic adenoviruses targeted to cancer stem cells

MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism

Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95

Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling

Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells

Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells

Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells

Radiation-induced cell signaling: inside-out and outside-in

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter

Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures

Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy

A Model System for the Design of Armed Replicating Adenoviruses Using p53 as a Candidate Transgene

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only